Edwards Lifesciences Corp Cash And Cash Equivalents At Carrying Value

• Edwards Lifesciences Corp showed a decrease of -3.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Edwards Lifesciences Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2010 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2008: $218.70 million | Q2 2009: $183.10 million | Q3 2009: $287.60 million | Q1 2010: $321.20 million | Q2 2010: $320.30 million | Q3 2010: $361.00 million | Q1 2011: $325.20 million | Q2 2011: $175.60 million | Q3 2011: $244.00 million | Q1 2012: $213.30 million | Q2 2012: $304.30 million | Q3 2012: $305.80 million | Q1 2013: $401.50 million | Q2 2013: $372.70 million | Q3 2013: $471.00 million | Q1 2014: $295.70 million | Q2 2014: $498.60 million | Q3 2014: $404.10 million | Q1 2015: $457.00 million | Q2 2015: $597.60 million | Q3 2015: $646.10 million | Q1 2016: $501.40 million | Q2 2016: $369.90 million | Q3 2016: $645.00 million | Q1 2017: $819.30 million | Q2 2017: $508.20 million | Q3 2017: $630.30 million | Q1 2018: $1.23 billion | Q2 2018: $1.23 billion | Q3 2018: $1.26 billion | Q1 2019: $709.20 million | Q2 2019: $726.80 million | Q3 2019: $1.19 billion | Q1 2020: $662.90 million | Q2 2020: $903.50 million | Q3 2020: $1.02 billion | Q1 2021: $1.17 billion | Q2 2021: $1.31 billion | Q3 2021: $1.51 billion | Q1 2022: $1.03 billion | Q2 2022: $1.20 billion | Q3 2022: $1.25 billion | Q1 2023: $872.50 million | Q2 2023: $1.04 billion | Q3 2023: $1.41 billion | Q1 2024: $1.22 billion | Q2 2024: $1.64 billion | Q3 2024: $3.68 billion | Q1 2025: $3.14 billion | Q2 2025: $3.27 billion | Q3 2025: $2.69 billion.
• Over the full 19 years of available data (2010 to 2025), Edwards Lifesciences Corp's Cash And Cash Equivalents At Carrying Value has grown by 641.7%.
• Historical annual values: Fiscal year 2025: $2.94 billion | Fiscal year 2024: $3.05 billion | Fiscal year 2023: $1.13 billion | Fiscal year 2022: $769.00 million | Fiscal year 2021: $862.80 million | Fiscal year 2020: $1.18 billion | Fiscal year 2019: $1.18 billion | Fiscal year 2018: $714.10 million | Fiscal year 2017: $818.30 million | Fiscal year 2016: $930.10 million | Fiscal year 2015: $718.40 million | Fiscal year 2014: $653.80 million | Fiscal year 2013: $420.40 million | Fiscal year 2012: $310.90 million | Fiscal year 2011: $171.20 million | Fiscal year 2011: $244.00 million | Fiscal year 2011: $175.60 million | Fiscal year 2011: $325.20 million | Fiscal year 2010: $396.10 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026